In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular lymphoma. The EPCORE FL-1 trial results show a 79% progression-free ...

Explore the Security Market Line in CAPM to assess stock value and risk, aiding investment decisions and enhancing portfolio management.

Adding condiments to your meals is a great way to enhance flavor and — potentially — add health benefits. However, not all are created equal. Some condiments contain unhealthy ingredients like ...